Sponsor or institution

Clinical trials and research at First Affiliated Hospital of Zhejiang University

• 82Clinical trials
• 1Country

Newest trials

All recruiting trials (82)

• Belumosudil vs. Ruxolitinib for hepatic cGVHD after HSCT

  This trial tests whether belumosudil or ruxolitinib works better for hepatic chronic GVHD after a stem cell transplant in people 12 and older.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT07794514

• Gastric protection after transplant: switch from PPI to teprenone to see effects on GVHD

  This trial tests whether switching from a proton pump inhibitor to teprenone after allogeneic HSCT changes the risk of acute graft-versus-host disease in patients with hematologic cancers.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou · NCT07791849

• Gut microbes and blood signals in sepsis-related liver and kidney injury

  This study tests whether gut microbes and blood markers differ in adults with sepsis who develop liver or kidney injury, compared with healthy volunteers.

  Recruiting at 6 sites First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang and 5 other locations · NCT07735182

• Eculizumab for high-risk TA-TMA in adult HSCT recipients

  This trial tests whether eculizumab can help adults with high-risk TA-TMA after allogeneic stem cell transplantation.

  Recruiting at 8 sites Phase 2 First Affiliated Hospital of Zhejiang University · Changsha, Hunan and 7 other locations · NCT07707687

• Single-dose vs divided-dose G-CSF for healthy stem cell donors

  This study tests whether giving G-CSF as one daily dose or split into two doses helps healthy donors mobilize enough stem cells for transplantation.

  Recruiting at 8 sites Phase 3 First Affiliated Hospital of Zhejiang University · Changsha, Hunan and 7 other locations · NCT07692841

• BY002 safety in healthy adults: a first-in-human, randomized, placebo-controlled study

  This study tests BY002 against placebo to see if it is safe and tolerable in healthy adults.

  Recruiting Phase 1 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT07640438

• How opioids affect sleep and mood in adults with cancer pain

  This observational study will test whether sleep and emotional well-being relate to opioid use in adults with moderate to severe cancer pain.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou · NCT07616648

• Targeted brain stimulation to help metabolic issues in people with bipolar disorder and obesity

  This study tests a brain stimulation approach called temporal interference stimulation to see if it can improve metabolism and stability in adults with bipolar disorder and obesity.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT07589647

• AI-guided reoperation decisions for bleeding after stomach cancer surgery

  This project will test whether an AI model can predict serious postoperative bleeding and help doctors decide if and when to reoperate for adults after radical gastrectomy for gastric cancer.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT07525765

• Etamsylate versus placebo to prevent bleeding after stem cell transplant

  This will test whether etamsylate can reduce bleeding in adults with very low platelets after hematopoietic stem cell transplantation.

  Recruiting Phase 3 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT07442513

• Chronotherapy of G-CSF for stem cell mobilization in healthy donors

  This trial tests whether giving G-CSF in the morning versus the evening improves the number of CD34+ cells in healthy donors benefiting allogeneic stem cell transplantation.

  Recruiting at 3 sites First Affiliated Hospital of Zhejiang University · Zhengzhou, Henan and 2 other locations · NCT07423728

• Adding venetoclax to fludarabine–melphalan conditioning for people over 50 with AML or MDS getting a donor stem cell transplant

  This tests whether adding venetoclax to standard fludarabine–melphalan conditioning helps people over 50 with AML or MDS who are having an allogeneic stem cell transplant.

  Recruiting at 18 sites Phase 3 First Affiliated Hospital of Zhejiang University · Fuzhou, Fujian and 17 other locations · NCT07396480

• Remimazolam sedation for high-risk patients undergoing bronchoscopy

  This test checks whether adding remimazolam to propofol and alfentanil lowers the chance of low oxygen (hypoxia) and circulatory problems during bronchoscopy in high-risk adults.

  Recruiting Phase 4 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang and 1 other locations · NCT07395596

• Supraglottic oxygen through a thin nasal tube during deep-sedation bronchoscopy

  This trial tests whether inserting a thin, wired endotracheal tube through the nose to deliver oxygen above the vocal cords helps prevent low oxygen levels in adults undergoing deep-sedation fiberoptic bronchoscopy.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT07389083

• Neoadjuvant trastuzumab rezetecan plus toripalimab for HR‑positive, HER2‑low breast cancer

  This trial will test whether giving trastuzumab rezetecan with toripalimab before surgery helps people with HR‑positive/HER2‑low breast cancer shrink tumors and achieve complete responses.

  Recruiting at 5 sites Phase 2 First Affiliated Hospital of Zhejiang University · Harbin and 4 other locations · NCT07383818

• Flow-diverting stents for distal brain aneurysms

  This will see if flow-diverting stents are safe and work well for adults (18–80) treated for distal brain aneurysms.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT07376590

• Neoadjuvant chemotherapy with sintilimab and bevacizumab for triple-negative breast cancer

  This trial will try adding the immunotherapy drug sintilimab and the blood‑vessel blocker bevacizumab to pre-surgery chemotherapy for women with stage II–III triple‑negative breast cancer to see if more tumors disappear completely before surgery.

  Recruiting at 2 sites Phase 2 First Affiliated Hospital of Zhejiang University · Hefei and 1 other locations · NCT07351487

• Iptacopan for high-risk TA-TMA after HSCT

  This study tests whether taking iptacopan by mouth can help patients with high-risk transplantation-associated thrombotic microangiopathy after HSCT fail conventional initial care.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, China · NCT07347990

• Irreversible electroporation to treat recurrent or metastatic neck lymph nodes from thyroid cancer

  This will try ultrasound-guided irreversible electroporation (IRE) to destroy recurrent or metastatic cervical lymph nodes in adults with thyroid cancer who have already had thyroid surgery and neck dissection.

  Recruiting at 3 sites First Affiliated Hospital of Zhejiang University · Guangzhou, Guangdong and 2 other locations · NCT07328243

• Romiplostim to speed platelet recovery after haploidentical stem cell transplant

  This trial will test whether weekly romiplostim helps adults with AML, MDS, or other blood cancers recover platelets faster after a haploidentical stem cell transplant.

  Recruiting Phase 1 First Affiliated Hospital of Zhejiang University · Hangzhou · NCT07321626

• First-line jaktinib plus corticosteroids for acute graft-versus-host disease

  This trial will test whether adding jaktinib to standard steroids helps adults with grade II–IV acute graft-versus-host disease after an allogeneic stem cell transplant.

  Recruiting Phase 1/2 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT07285889

• Safety and feasibility of irreversible electroporation (IRE) for early-stage breast cancer

  This trial will test whether irreversible electroporation (IRE) can be safely used before surgery to treat women with small (≤2.0 cm), treatment-naïve invasive ductal breast cancer visible on ultrasound and MRI.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang and 1 other locations · NCT07263451

• Gilteritinib with Venetoclax and Azacitidine, then High‑Dose Cytarabine and Gilteritinib Maintenance for Newly Diagnosed FLT3‑ITD AML

  This approach tests whether combining gilteritinib with venetoclax and azacitidine for induction, followed by DeepScan‑guided high‑dose cytarabine consolidation and gilteritinib maintenance, can produce deep remissions and allow fit adults with newly diagnosed FLT3‑ITD AML to avoid transplant.

  Recruiting Phase 2 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT07259707

• Time-dependent diffusion MRI for prostate cancer microstructural imaging

  The team will test whether time-dependent diffusion MRI can help doctors more accurately diagnose prostate cancer in men who are suspected of having the disease.

  Recruiting at 5 sites First Affiliated Hospital of Zhejiang University · Beijing, Beijing Municipality and 5 other locations · NCT07249281

• A-CAR028 for relapsed or refractory acute myeloid leukemia

  This study will try A-CAR028, a CAR-T cell therapy, in adults with relapsed or refractory AML to see if it is safe and helps control the leukemia.

  Recruiting Phase 1 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT07198867

• Adding etanercept to ruxolitinib for severe steroid-refractory acute GVHD

  This trial will test whether adding the TNF blocker etanercept to ruxolitinib helps people with severe acute GVHD that did not respond to steroids.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT07184853

• Venetoclax-enhanced BUCY versus standard BUCY conditioning for high‑risk AML and MDS before allogeneic stem cell transplant

  This will test whether adding venetoclax to BUCY conditioning before allogeneic stem cell transplant helps patients aged 12–60 with high‑risk AML or MDS stay in remission longer.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT07183878

• New-generation GMA versus conventional inflatable laryngeal mask for airway management during general anesthesia

  This trial will test whether the new GMA laryngeal mask provides safer, more stable, and more comfortable airway management than the conventional inflatable laryngeal mask for adults having elective surgery under general anesthesia.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT07177586

• Alternating venetoclax+azacitidine and low-dose cladribine+homoharringtonine+cytarabine for unfit newly diagnosed AML

  This phase II trial tests whether alternating venetoclax + azacitidine with low-dose cladribine + homoharringtonine + cytarabine can help people aged ≥60 or otherwise unfit with newly diagnosed AML become MRD negative and achieve better disease control.

  Recruiting at 5 sites Phase 2 First Affiliated Hospital of Zhejiang University · Beijing, Beijing Municipality and 4 other locations · NCT07172204

• Dragon boat training versus home exercise to improve function and quality of life after breast cancer surgery

  This study will test whether organized, supervised dragon boat training or unsupervised home exercise better improves physical function and quality of life in women after breast cancer surgery.

  Recruiting Phase 2 First Affiliated Hospital of Zhejiang University · Hangzhou · NCT07162298

• Lecanemab treatment in early Alzheimer's disease

  This project will test whether routine blood tests can track amyloid removal after lecanemab in people with early Alzheimer's who have positive amyloid PET scans.

  Recruiting at 2 sites First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang and 1 other locations · NCT07153848

• Examining metastatic lymph nodes in each part of the stomach's mesentery during gastrectomy

  This project will see if the number and location of metastatic lymph nodes across the six stomach mesenteries predict outcomes for adults undergoing D2 plus complete mesogastric excision for gastric cancer.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT07139418

• 18F‑Pentixafor PET imaging for blood cancers

  This will test whether 18F‑Pentixafor PET scans help diagnose, stage, and check treatment response in adults with suspected or confirmed hematologic malignancies.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT07122674

• Blinatumomab plus donor lymphocyte infusion to prevent relapse after transplant in high-risk Ph-negative B‑cell ALL

  This trial tests whether giving blinatumomab together with donor lymphocyte infusions can help prevent relapse in people aged 14–65 with high‑risk Philadelphia chromosome–negative B‑cell acute lymphoblastic leukemia after an allogeneic stem cell transplant.

  Recruiting Phase 2 First Affiliated Hospital of Zhejiang University · Hangzhou · NCT07105579

• 18F‑DFA PET scan to visualize liver damage

  This study will test whether 18F‑DFA PET scans can show liver damage in adults with liver injury compared with blood tests or biopsy.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT07050550

• Immune map of pancreatic cancer evolution

  This project will collect blood, tissue, imaging, and clinical data from people with pancreatic cancer, benign pancreatic lesions, and healthy volunteers to try to build an AI-based immune map that can detect and track pancreatic cancer.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT07034339

• Anti-blood-vessel therapy after immunotherapy for advanced bile duct or gallbladder cancer.

  This study will test whether giving the anti-angiogenic drug anlotinib after first-line immunotherapy helps people with advanced bile duct or gallbladder cancer live longer without their disease getting worse.

  Recruiting Phase 2 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT07025174

• Temporal interference stimulation for bipolar depression

  This trial will test whether temporal interference brain stimulation can help adults with bipolar depression and uses MRI and EEG to see how the brain responds.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT07021508

• Blinatumomab before allogeneic stem cell transplant for MRD‑negative high‑risk B‑cell ALL

  This test sees if a short course of blinatumomab given before an allogeneic stem cell transplant helps adults (18–65) with high‑risk, BCR::ABL1‑negative B‑cell ALL who are MRD‑negative to lower relapse and improve survival.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT07003737

• Neoadjuvant chemotherapy with Toripalimab for HR+/HER2- breast cancer

  This study is testing if adding a new immunotherapy drug called Toripalimab to standard chemotherapy can help people with HR+/HER2- breast cancer respond better to treatment.

  Recruiting at 2 sites Phase 3 First Affiliated Hospital of Zhejiang University · Hangzhou and 12 other locations · NCT06977893

• Pre-surgery chemotherapy with anlotinib and benmelstobart for HR+/HER2- breast cancer

  This trial tests whether adding anlotinib and benmelstobart to pre-surgery chemotherapy helps people with hormone receptor–positive, HER2‑negative breast cancer achieve a complete response before surgery.

  Recruiting Phase 2 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang and 2 other locations · NCT06874933

• Evaluating a new therapy for benign prostatic hyperplasia

  This study tests a new treatment called steep pulse therapy for men with benign prostatic hyperplasia to see if it works better than the usual medication.

  Recruiting at 10 sites First Affiliated Hospital of Zhejiang University · Hefei, Anhui and 9 other locations · NCT06867315

• Short-course radiotherapy followed by CAPEOX with iparomlimab and tuvonralimab for resectable MSS/pMMR locally advanced rectal cancer

  This trial will test whether adding two immunotherapy drugs (iparomlimab and tuvonralimab) to short-course radiation and CAPEOX chemotherapy helps patients with resectable locally advanced MSS/pMMR rectal cancer keep their rectum and avoid major surgery.

  Recruiting Phase 2 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06864013

• Evaluating 18F-MFBG PET Imaging for Neuroblastoma

  This study is testing a new type of PET scan using a special dye to see if it can help doctors better diagnose and understand the extent of neuroblastoma in patients.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06852807

• Short-course radiation plus CAPEOX chemotherapy and serplulimab for MSS/pMMR rectal cancer with limited metastases

  This trial will try combining short-course radiotherapy, CAPEOX chemotherapy, and the immunotherapy serplulimab to see if it helps people with MSS/pMMR rectal cancer who have a small number of metastases.

  Recruiting Phase 2 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06850103

• Combining chemotherapy with pyrotinib and trastuzumab for HER2-positive breast cancer

  This study is testing whether combining chemotherapy with two targeted drugs, pyrotinib and trastuzumab, can help people with HER2-positive breast cancer respond better to treatment before surgery.

  Recruiting Phase 2 First Affiliated Hospital of Zhejiang University · Hangzhou · NCT06832904

• Evaluating 18F-MFBG PET Imaging for Pheochromocytoma

  This study is testing a new imaging method called 18F-MFBG PET to see if it can help people with pheochromocytoma get better and faster pictures of their tumors compared to traditional methods.

  Recruiting at 2 sites First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang and 1 other locations · NCT06813742

• Combining Venetoclax, Olverembatinib, and Prednisone for treating Ph+ B-ALL

  This study is testing a new combination of three drugs to see if it can help adults with a specific type of aggressive leukemia feel better and live longer.

  Recruiting Phase 2 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06754267

• Universal T-cell therapy for treating severe aGVHD

  This study is testing a new type of T-cell therapy to see if it can help people with severe acute graft-versus-host disease who haven't responded to standard treatments after a stem cell transplant.

  Recruiting at 2 sites Phase 1 First Affiliated Hospital of Zhejiang University · Fuzhou, Fujian and 1 other locations · NCT06750133

• Combining Blinatumomab with Reduced-dose Chemotherapy for B-ALL Treatment

  This study is testing a new treatment that combines Blinatumomab with lower doses of chemotherapy to see if it helps adults with a type of leukemia called precursor B-cell acute lymphoblastic leukemia feel better and achieve a complete response.

  Recruiting Phase 2 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06742515

• Treatment for relapsed or refractory T-cell acute leukemia/lymphoma

  This study is testing a new combination treatment for people with relapsed or hard-to-treat T-cell acute leukemia or lymphoma to see if it can help them go into complete remission.

  Recruiting Phase 2 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06742463

• Checking for lymph node spread and tumor deposits in the posterior gastric mesentery after distal stomach cancer surgery

  This project will check if adults having distal stomach cancer surgery (distal gastrectomy with D2 lymphadenectomy plus complete mesogastric excision) have lymph node metastases or tumor deposits in the posterior gastric mesentery.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06736847

• Tumor deposits at the fusion of the right and left gastric mesenteries after proximal gastrectomy

  We will see if tumor tissue is present at the fusion site between the right and left gastric mesenteries in adults having proximal gastrectomy for gastric cancer.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06728891

• Lymph node spread in the short gastric mesentery after total gastrectomy for stomach cancer

  This project will examine removed short gastric mesentery tissue to see how often cancer has spread to those lymph nodes in people having total gastrectomy for gastric cancer.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06728878

• Using Remimazolam for Sedation in Patients After Heart Surgery

  This study tests if a new sedative called remimazolam can help heart surgery patients recover better and get off breathing machines faster compared to a standard sedative.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06716840

• Combining radiotherapy and chemotherapy with Toripalimab for advanced breast cancer

  This study is testing if combining radiotherapy and chemotherapy with a new drug called Toripalimab can help people with advanced breast cancer feel better and improve their treatment outcomes.

  Recruiting Phase 2 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06705127

• Combining chemotherapy with Toripalimab for treating triple negative breast cancer

  This study is testing if combining chemotherapy with Toripalimab can help women with triple negative breast cancer respond better to treatment before surgery.

  Recruiting at 8 sites Phase 2 First Affiliated Hospital of Zhejiang University · Nanchang, Jiangxi and 12 other locations · NCT06682195

• Evaluating LY-M003 Injection for Wilson Disease

  This study is testing a new gene therapy called LY-M003 to see if it is safe and effective for people with Wilson Disease.

  Recruiting Early Phase 1 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06650319

• Combination treatment for relapsed or refractory acute myeloid leukemia

  This study is testing a new combination of three medications to see if it can help people with relapsed or refractory acute myeloid leukemia feel better and improve their treatment results.

  Recruiting Phase 2 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06621212

• New treatment for elderly patients with acute myeloid leukemia

  This study is testing a new combination treatment for older patients who have just been diagnosed with acute myeloid leukemia to see if it helps them live longer without their cancer getting worse.

  Recruiting Phase 2 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06621199

• Neoadjuvant chemotherapy with Toripalimab for HR+/HER2- breast cancer

  This study is testing if adding Toripalimab to standard chemotherapy can help women with HR+/HER2- breast cancer respond better to treatment before surgery.

  Recruiting at 3 sites Phase 2 First Affiliated Hospital of Zhejiang University · Hangzhou and 10 other locations · NCT06611813

• Combining Blinatumomab and Venetoclax with Inotuzumab Ozogamicin for B-ALL Treatment

  This study is testing a new combination of three medications to see if it can help adults with newly diagnosed B-cell acute lymphoblastic leukemia live longer and healthier lives.

  Recruiting Phase 2 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06554626

• Orelabrutinib combined with BR/G for untreated Marginal Zone Lymphoma

  This study is testing if a new drug called Orelabrutinib, combined with other treatments, can help younger and older patients with untreated Marginal Zone Lymphoma feel better and have fewer side effects.

  Recruiting Phase 2 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06504940

• Exploring the effects of sleep loss on aging and cognitive decline

  This study is testing how not getting enough sleep affects thinking and aging in healthy people and those with memory problems or Alzheimer's disease.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06492109

• Using methylene blue to treat severe septic shock

  This study is testing if methylene blue can help people with severe septic shock survive better and improve their organ function compared to a placebo.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06481410

• Comparing stem cell transplant and non-transplant treatments in multiple myeloma patients

  This study is testing whether a stem cell transplant works better than other treatments for multiple myeloma patients who have very low levels of the disease after their initial therapy.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06463717

• Using Modified Si Jun Zi Tang with chemotherapy for lung cancer treatment

  This study tests if adding a traditional Chinese medicine called Modified Si Jun Zi Tang to standard chemotherapy and immunotherapy can help people with non-small cell lung cancer do better during and after surgery.

  Recruiting Phase 2 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06445881

• Observing micro-movements in patients with prolonged disorders of consciousness

  This study is trying to see if tiny movements in patients with prolonged disorders of consciousness can help us understand their level of awareness and improve their care.

  Recruiting First Affiliated Hospital of Zhejiang University · Hanzhou, Zhejiang · NCT06406413

• Effects of magnetic stimulation on sleep and cognition in Alzheimer's patients

  This study is testing whether a type of magnetic treatment can improve sleep and thinking skills in people with mild-to-moderate Alzheimer's disease.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06385106

• Oral all-trans retinoic acid plus toripalimab for advanced or metastatic triple-negative breast cancer

  This test tries whether taking oral all‑trans retinoic acid together with the immunotherapy toripalimab helps people with locally advanced, recurrent, or metastatic triple‑negative breast cancer who have failed at least two prior treatments.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang Province, P.R. China · NCT06371274

• Comparing a new treatment with traditional chemotherapy for a type of leukemia

  This study is testing a new treatment for young and middle-aged people with a tough type of leukemia to see if it works better than standard chemotherapy.

  Recruiting Phase 3 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06361329

• Using advanced imaging to evaluate myelofibrosis

  This study is testing new imaging techniques to see if they can help doctors better understand and monitor myelofibrosis without needing invasive procedures like bone marrow biopsies.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06164561

• Understanding the role of microbiomes in severe pneumonia

  This study is trying to see how the bacteria in the lungs and gut affect how people with severe pneumonia get sick and recover.

  Recruiting at 14 sites First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang and 14 other locations · NCT06114784

• Examining immune cells in children with ADHD

  This study looks at the immune cells in children with ADHD to see how they differ from kids without ADHD and how these differences might relate to their symptoms and brain function.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06109337

• Understanding micro-expressions in patients with prolonged disorders of consciousness

  This study is trying to see if watching emotional videos can help understand the tiny facial expressions of patients with prolonged disorders of consciousness and improve how doctors assess their awareness.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06088628

• Using accelerated theta-burst stimulation to treat major depressive disorder

  This study is testing if a new brain stimulation technique can help people with major depression feel better faster than usual treatments, especially for those who haven't taken medication yet.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT05913960

• Combining chemotherapy with serplulimab for advanced gastric cancer

  This study is testing if adding a new drug called serplulimab to standard chemotherapy can help people with advanced stomach cancer do better than those who only get chemotherapy.

  Recruiting Phase 2 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang and 4 other locations · NCT05872685

• Combining chemotherapy with Toripalimab for advanced gastric cancer

  This study is testing if combining a specific chemotherapy with Toripalimab can help people with advanced gastric cancer feel better and improve their treatment results.

  Recruiting Phase 2 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang and 7 other locations · NCT05729646

• Accelerated rTMS for treatment-resistant depression

  This study is testing a faster way of using brain stimulation to see if it can help people with depression who haven't found relief from other treatments.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT05607654

• Longitudinal study on bipolar disorder and major depressive disorder

  This study is trying to find new biological markers that can help doctors diagnose and treat people with bipolar disorder and major depressive disorder by looking at how gut health and brain function are connected.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT05480150

• Using Imatinib Mesylate before surgery for gastrointestinal stromal tumors

  This study is testing if taking imatinib mesylate before surgery can help people with high-risk gastrointestinal stromal tumors have better outcomes and live longer.

  Recruiting Phase 2 First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT04933669

• Combining anticoagulant and antiplatelet therapy after iliac vein stenting

  This study is testing if using a combination of blood thinners and anti-clotting medication after iliac vein stenting can help people with deep vein thrombosis keep their veins open and healthy for a year.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT04694248

Quick answers

How many clinical trials run by First Affiliated Hospital of Zhejiang University are recruiting right now?

82, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 26, Phase 3: 5, Phase 1: 4, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →